Pornography Abstinence and Nocturnal Erections in Adult Men
Condition(s) studied
Investigational drug(s) / intervention(s)
Pornography Abstinence: Participants will attempt to abstain from all pornography use for 30 consecutive days. Any deviations from abstinence are self-reported and logged for contextual analysis.
Study summary
The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.
Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.
Eligibility
Primary outcome measure(s)
- Change in Nocturnal Penile Tumescence — Baseline Day to Day 38
Measure: Adam Sensor - Nocturnal Erection Tracking Description: Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Efforia | New York | New York | Recruiting |
More Efforia, Inc trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07618104 on ClinicalTrials.gov ↗ ← All trials in the USA